Peregrine Capital Management LLC Tandem Diabetes Care Inc Transaction History

Peregrine Capital Management LLC

  • $3.18 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023
BUY
$19.33 - $36.22 $1.02 Million - $1.92 Million
52,897 Added 27.77%
243,355 $5.05 Million
Q2 2023

Jul 26, 2023
SELL
$24.18 - $42.46 $1,402 - $2,462
-58 Reduced 0.03%
190,458 $4.67 Million
Q1 2023

Apr 26, 2023
BUY
$35.86 - $46.5 $201,497 - $261,283
5,619 Added 3.04%
190,516 $7.74 Million
Q4 2022

Jan 10, 2023
SELL
$35.49 - $56.15 $198,531 - $314,103
-5,594 Reduced 2.94%
184,897 $8.31 Million
Q3 2022

Oct 26, 2022
BUY
$43.76 - $68.97 $8.34 Million - $13.1 Million
190,491 New
190,491 $9.12 Million

Others Institutions Holding TNDM

# of Institutions
359
Shares Held
72.2M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.37B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email